T

Tenax Therapeutics
D

TENX

14.660
USD
1.36
(10.23%)
مغلق
حجم التداول
9,020
الربح لكل سهم
-1
العائد الربحي
-
P/E
-20
حجم السوق
91,530,810
أصول ذات صلة المقالات

العنوان: Tenax Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North Americanrights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved EjectionFraction.